Deutsche Bank’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Deutsche Bank’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,447	Closed	-$409K	–	4167
2022 Q2	$409K	Buy	+7,447	New	+$391K	﹤0.01%	2735
2018 Q4	–	Sell	-5,681	Closed	-$386K	–	5530
2018 Q3	$386K	Buy	5,681 +2,207	+64%	+$200K	﹤0.01%	3916
2018 Q2	$411K	Sell	3,474 -2,570	-43%	-$258K	﹤0.01%	3949
2018 Q1	$500K	Buy	+6,044	New	+$685K	﹤0.01%	3699
2017 Q3	–	Sell	-3	Closed	–	–	5177
2017 Q2	$0	Sell	3 -12	-80%	-$612	﹤0.01%	5194
2017 Q1	$0	Buy	+15	New	+$872	﹤0.01%	5177
2016 Q4	–	Sell	-4,257	Closed	-$309K	–	5145
2016 Q3	$309K	Buy	4,257 +3,879	+1,026%	+$300K	﹤0.01%	3429
2016 Q2	$29K	Sell	378 -66	-15%	-$12.6K	﹤0.01%	4636
2016 Q1	$119K	Buy	444 +294	+196%	+$93.9K	﹤0.01%	3922
2015 Q4	$90K	Buy	+150	New	+$101K	﹤0.01%	4112

Other funds holding SRRA

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Deutsche Bank's SRRA Position: Q3 2022 in Review

Deutsche Bank sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 7,447 shares — an estimated $409K sold.

Deutsche Bank first reported a position in SRRA in Q4 2015 and held it in 10 quarters. The position peaked at $500K in Q1 2018. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

Deutsche Bank reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Deutsche Bank sold 7,447 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $409K.
Deutsche Bank first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
Deutsche Bank's Sierra Oncology, Inc. Common Stock position peaked at $500K in Q1 2018.
1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Deutsche Bank's 13F filing for Q3 2022, filed 14 Nov 2022.